Thursday, March 20, 2025 2:44:10 PM
Credit where due, criticism where due, I'm consistent.
I'm not sharing a private conversation with a message board, no more than you will.
The proof is in the fact that over the years whenever we've had issues with Sohm, controversies...it's just a matter of time before the Company responds with a Tweet or a PR that reveals they've been listening in, or have a bug in their ear.
Dewey listens in...
And here...
____
While I have previously enjoyed Sohm Gummies, I've lost my desire to buy any more of them, why should I support the Company that disrespects shareholders...
I'm not sharing a private conversation with a message board, no more than you will.
The proof is in the fact that over the years whenever we've had issues with Sohm, controversies...it's just a matter of time before the Company responds with a Tweet or a PR that reveals they've been listening in, or have a bug in their ear.
Dewey listens in...
And here...
We have received some questions about our recent press release and would like to share that we did receive orders for our ABBIE kit. However, our leadership team and our legal advisors identified the risks associated with selling unrestricted ABBIE kits.
— SOHM, Inc. (@sohminc) March 12, 2025
Due to our global patent…
____
While I have previously enjoyed Sohm Gummies, I've lost my desire to buy any more of them, why should I support the Company that disrespects shareholders...
Recent SHMN News
- SOHM Inc. Releases White Paper on ABBIE, a Cas9-Guided Integrase Enabling Stable Gene Integration and Creation of SKOV3-GYS1 Cell Line for Drug Discovery • ACCESS Newswire • 11/06/2025 02:30:00 PM
- SOHM Notes FDA's Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development • ACCESS Newswire • 11/04/2025 02:30:00 PM
